Introduction {#Sec1}
============

Seasonal influenza is a common and contagious illness with an annual attack rate estimated at 5--10% in adults \[[@CR1]\], pregnant women being at increased risks of morbidity and death \[[@CR1]\], even those with no comorbidities \[[@CR2]\].

Seasonal influenza vaccination during pregnancy reduces the risk of an influenza diagnosis by 50% \[[@CR3]\]. It also confers effective protection up to the age of 6 months for newborns whose mother was vaccinated during pregnancy \[[@CR4]\] with a reduction of 63% in influenza cases and of 29% in episodes of febrile respiratory illness \[[@CR5]\]. A review of 15 years of surveillance data covering 750 million doses of the vaccine in the United States revealed no data that raised concerns about its safety in general population \[[@CR6]\], neither for the foetus nor the mother, as showed by other studies \[[@CR7]--[@CR10]\]. As a result, the World Health Organization (WHO) \[[@CR11]\], the American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention (CDC) \[[@CR12]\], recommend seasonal influenza vaccination for pregnant women, regardless of gestational age.

Several previous studies have identified factors affecting pregnant women's decisions about whether to get a seasonal influenza vaccination \[[@CR13]--[@CR17]\]. Despite this, the vaccination coverage in pregnant women remains very low: 7% in France in 2016 \[[@CR18]\], 45% in England in 2017 \[[@CR19]\], and 37% in the US in 2017 \[[@CR20]\] and lower than the Healthy People 2020 target of 80% \[[@CR21]\]. Therefore, to explore why the vaccination coverage remains very low, we conducted one of the largest cohort studies on this topic to date to evaluate women motivations to be vaccinated or not. We also investigated a large number of possible determinants, in order to find strategies to improve seasonal influenza vaccination rate.

Material and methods {#Sec2}
====================

Study design and sampling method {#Sec3}
--------------------------------

We conducted a prospective single centre observational study during the 2014--2015 influenza season in a level-III University maternity unit in Lille, France, with an approximate birth rate of 5000 births/year. In France, women must obtain a prescription and a reimbursement form from their general practitioner or antenatal care provider, purchase the vaccine from a drugstore and the vaccine may then be administered during another appointment with the healthcare worker conducting the antenatal care or by a nurse at home. The vaccine is cost-free if the woman provides the drugstore with a reimbursement form. Eligible women for the study were all the women giving birth in our maternity unit and having received prenatal care during the 2014--2015 vaccination campaign between November 17, 2014, and June 5, 2015. The study excluded those younger than 18 years, or who did not speak French, or had a contraindication to the influenza vaccination, or refused to participate. For all participants written consent was obtained.

Variables considered in our study {#Sec4}
---------------------------------

The outcome of interest was seasonal influenza vaccination uptake, reported by the pregnant women as part of a self-completed questionnaire. Data were collected from medical forms and from a self-completed paper questionnaire (see Additional file [1](#MOESM1){ref-type="media"} and Additional file [2](#MOESM2){ref-type="media"})offered by the clinical staff to all eligible women during their postpartum hospitalisation. Variables considered as possible determinants of vaccine uptake were maternal sociodemographic characteristics: age, educational level and living or not with her partner;maternal medical characteristics before pregnancy: pre-existing comorbidities for which influenza vaccination is indicated according to French guidelines (grouped into major categories: respiratory, cardiac, neurological, kidney-related, haematological and immune-related, diabetes, chronic liver disease, and obesity with Body Mass Index (BMI) ≥ 40 kg/m^2^ \[[@CR22]\]), being vaccinated against influenza before this pregnancy, number of previous deliveries, history of preterm delivery before 34 weeks;characteristics of the current pregnancy: smoking status, obstetrical complications defined as gestational diabetes, gestational hypertension, pre-eclampsia, HELLP syndrome, infections and foetal growth restriction;antenatal care: the starting time of prenatal care at the hospital, the healthcare worker providing the prenatal care being a gynaecologist-obstetrician, general practitioner, hospital midwife, private midwife, profession of the healthcare worker recommending the vaccination, the provision of a reimbursement form for the vaccine;maternal knowledge about influenza and its vaccine: frequency of influenza, knowledge of serious complications of influenza for mothers and their infants, the frequency of vaccine complications for mothers and their infants, knowledge about the recommendation of the vaccine in pregnancy.

Data about maternal sociodemographic characteristics, maternal medical characteristics before pregnancy, and characteristics of this pregnancy were extracted from the medical forms. Prenatal care and maternal knowledge about influenza and its vaccine were extracted from the self-completed questionnaire. The questionnaire was adapted from the questionnaire used by Yudin et al. to assess women's knowledge of influenza and its vaccination \[[@CR23]\]. We also created a "knowledge score" about this disease and its vaccine before the study with a multidisciplinary group of experts including obstetricians, infectious disease specialists, general practitioners, and statisticians from the potential responses to the self-completed questionnaire (see Additional file [3](#MOESM3){ref-type="media"}). The score ranged from 0 to 9 points and a woman was considered to have good knowledge when her score was higher than the last quartile of the score distribution, that is, a knowledge score greater than 5.4/9 in our study.

Statistical analyses {#Sec5}
--------------------

To identify determinants associated with vaccination uptake, we conducted bivariate and multivariate logistic regression analysis. Dependent variables included in the regression model were those previously described as determinants of vaccine uptake in scientific literature or associated with vaccination uptake in bivariate analysis with a *p*-value less than 0.20. We have calculated variance inflation factor to check for multicollinearity and all the variables have a VIF \< 2.0. In order to evaluate if the profession of the healthcare worker recommending the vaccination was a relevant factor, we conducted an analysis only on women to whom vaccination had been recommended during pregnancy. Percentages were compared using the chi-2 test or Fisher's exact test, depending on the number of individuals. We calculated adjusted odds ratios (aORs) with their 95% confidence interval (95% CI). The difference was considered significant if *p* \< 0.05. The analyses were performed with STATA software version 13.0.0 (Copyright 1985--2013 StataCorp LP, StataCorp, College Station, TX, USA).

Our study adheres to the STROBE guidelines. The CEROG (committee for ethics in research in gynaecology and obstetrics, n° CEROG OBS 2014-11-01) approved of this study.

Results {#Sec6}
-------

Of the 2862 women who gave birth during the inclusion period, 370 did not receive the questionnaire (12.9%), 138 were excluded from the study (5.5%), 216 women received the questionnaire but did not return it (9.2%), and 24 women did not answer the question about their influenza vaccination. Therefore, 2045 women (86.9%) were included in the analysis (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) flow diagram of the participants in this study

One third of the women questioned (35.5%) reported they had been vaccinated against seasonal influenza during their pregnancy. Table [1](#Tab1){ref-type="table"} presents the maternal factors associated with this vaccination. Women were vaccinated more often if they had at least one comorbidity (40.0%), if they had previously been vaccinated against influenza (50.9%), especially during a previous pregnancy (92.0%), and if they were nulliparous (41.0%). Higher vaccination rates were also observed for women who perceived influenza as a common disease (37.6%), or its vaccination as having a very low rate of complications for mothers (52.3%) or babies (54.6%), and when they had good knowledge about influenza (61.7%). Note that educational level and severe obesity (BMI \> 40 kg/m^2^) were not associated with vaccination. Table 1Factors associated with uptake of influenza vaccination during pregnancy according to mothers' characteristics (*n* = 2045)Vaccinatedn/N^a^%*p*^*¥*^Total725/204535.5Age  \< 25 years97/30631.70.49  ≥ 25 and \< 30 years230/64535.7  ≥ 30 and \< 35 years246/68535.9  ≥ 35 years151/40837.0Educational level Primary28/6940.60.59 Secondary or technical132/38634.2 Higher study564/158835.5Lives with partner Yes643/180335.70.56 No81/24033.7Smoked during pregnancy Yes144/43733.00.22 No578/160236.1At least one comorbidity^b^191/47840.00.02 Respiratory48/14233.8 Cardiac28/7437.8 Neurological36/9338.7 Nephrological9/1850.0 Haematologic-immune31/5457.4 Diabetes16/3053.3 Chronic liver disease10/2147.6 BMI ≥ 40 kg/m^2^13/2429.5Previous influenza vaccination Yes, outside pregnancy279/54850.9\< 0.001 Yes, during a previous pregnancy185/20192.0 No249/123520.2Number of previous deliveries 0358/87441.0\< 0.001 1225/70432.0  ≥ 2141/46530.3History of preterm delivery \< 34 weeks Yes33/7643.40.14 No691/196735.1Obstetric complications^c^ Yes288/81235.50.98 No435/122835.4Perceived frequency of influenza in the general population Very low to low49/18027.20.02 Intermediate217/63134.4 High452/120237.6Perceived frequency of vaccine complications in pregnant women Very low352/67352.3\< 0.001 Low154/50930.3 Intermediate139/59723.3 High52/14136.9Perceived frequency of vaccine complications in babies Very low375/68754.6\< 0.001 Low122/41429.5 Intermediate128/62120.6 High64/18135.4Good knowledge of influenza^±^ Yes374/60661.7\< 0.001 No351/143924.4^a^Number of women vaccinated among the total number of women in the subclass^b^Presence of at least one comorbidity that is an indication for influenza vaccination even outside of pregnancy according to the 2012 HAS guidelines \[32\]^c^Gestational diabetes, hypertension, pre-eclampsia, HELLP syndrome, infections, other (anaemia, foetal growth restriction, etc.)¥p value was calculated by Chi 2 test±good knowledge of influenza was defined by a knowledge score \> 5.4/9

The prenatal care factors associated with vaccination (Table [2](#Tab2){ref-type="table"}) were hospital-based prenatal care in their first trimester of pregnancy (55.0%), having received a vaccination recommendation (47.0%), especially by a general practitioner (57.3%) or a midwife in private practice (54.3%), receipt of a vaccine reimbursement form (52.4%), or information from a healthcare worker (43.8%). Table 2Factors associated with uptake of influenza vaccination during pregnancy according to prenatal care (n = 2045)Vaccinatedn/N^a^%*p*^*¥*^Total725/204535.5Time at which prenatal care started First trimester72/13155.0\< 0.001 Second trimester410/110637.1 Third trimester241/79830.2Healthcare worker providing the prenatal care Assistant Chief Resident50/12938.80.80 Hospital staff physician274,73437.3 Hospital staff midwife322/89436.0 Intern64/18734.2Healthcare worker recommending vaccination Gynaecologist-Obstetrician237/46750.7\< 0.001 General practitioner82/14357.3 Hospital staff midwife229/57140.1 Midwife (in private practice)25/4654.3 Several different professionals76/15848.1 Occupational doctor, national health insurance56/10752.3Types of information received Recommendation for vaccination with a form for reimbursement524/98753.1\< 0.001 Recommendation for vaccination without a form for reimbursement176/50135.1 No recommendation for vaccination but reimbursement form provided3/1915.8 Neither proposal for vaccination nor reimbursement form11/5072.2Vaccination recommendation Yes711/151447.0\< 0.001 No14/5282.7Receipt of a vaccine reimbursement form Yes527/100652.4\< 0.001 No187/100818.6Sources of information about influenza vaccination (multiple responses possible) At least one healthcare worker604/137843.8\< 0.001 Not a healthcare worker^b^117/61119.1^a^Number of women vaccinated among the total number of women in the subclass^b^All answers possible except healthcare workers: the media, discussion groups, family and friends, health authorities, and others¥p value was calculated by Chi 2 test

Women motivations to be vaccinated or not are summarised in Table [3](#Tab3){ref-type="table"}. The major motivation to be vaccinated was that the vaccine protects the baby (83%) and at the second place that the vaccine protects her (73%). A third of the vaccinated women claimed as motivation that they had received sufficient information about the benefits of the vaccine. However, there was a variety of reasons to not be vaccinated: some did not have enough information about the benefit and risk of the vaccine (32%), some were rather "against" vaccines in general (26%) and others were scared for the baby's health (24%). Table 3Women motivations to be vaccinated or not against influenzan%Motivations to be vaccinated (*N* = 325) The vaccine protects me52973.0 The vaccine protects my baby59982.6 I have received sufficient information on the benefits of the vaccine21730.0 I am more "in favour" of vaccines in general17223.7 The vaccine is fully reimbursed648.8 Other233.2Motivations not to be vaccinated (*N* = 1320) I did not know there was a vaccine554.2 I was scared for my baby's health31724.0 I was scared for my health16612.6 I did not have enough information about the benefits and risks42232.0 I am rather "against" vaccines in general35026.5 Other38729.3

On logistic regression analysis (Table [4](#Tab4){ref-type="table"}), statistically significant determinants of vaccination were a previous influenza vaccination (50.9% vs 20.2%, OR 4.1, 95% CI 3.3--5.5), nulliparity (41.0% vs 30.3%, OR 2.5, 95% CI 1.7--3.7), history of preterm delivery \< 34 weeks (43.4% vs 35.1%, OR 2.3, 95% CI 1.1--4.9), perception that the frequency of vaccine complications for babies is very low (54.6% vs 35.4%,OR 1.1, 95% CI 0.5--2.2), the mothers' good knowledge of influenza and the vaccine (61.7% vs 24.4%,OR 3.1, 95% CI 2.2--4.4), hospital-based prenatal care in their first trimester of pregnancy (55% vs 30.2%, OR 2.1, 95% CI 1.2--3.7), vaccination recommendations (47.0% vs 2.7%, OR 18.8, 95% CI 10.0--35.8) and when this recommendation was done by a general practitioner (57.3% vs 50.7% for Gynaecologist-Obstetrician, OR 1.6 CI 1.0--2.8), receipt of a vaccine reimbursement form (52.4% vs 18.6%, OR 2.0, 95% CI 1.5--2.7), and having received information about the vaccine from at least one healthcare worker (43.8% vs 19.1%, OR 1.8, 95% CI 1.3--2.6). Table 4Logistical regression analysis of the factors associated with influenza vaccination uptake during pregnancy in this study (*n* = 1751)ORaOR^a^95% CI %^b^*p*^*¥*^Previous influenza vaccination No.11\< 0.001 Yes, not during pregnancy4.14.13.1--5.5 Yes, in a previous pregnancy45.843.922.8--84.4Number of previous deliveries  ≥ 211\< 0.001 11.11.61.1--2.4 01.62.51.7--3.7History of preterm delivery \< 34 weeks No.110.02 Yes1.42.31.1--4.9Perceived frequency of vaccine complications in babies High110.005 Intermediate0.30.90.5--1.5 Low0.20.50.3--0.9 Very low0.41.10.5--2.2Good knowledge of influenza No.11\< 0.001 Yes5.03.12.2--4.4Hospital-based prenatal care beginning Third trimester110.02 Second trimester1.41.20.9--1.6 First trimester2.82.11.2--3.7Vaccination recommendation No.11\< 0.001 Yes32.518.810.0--35.8Receipt of a vaccine reimbursement form No.11\< 0.001 Yes4.82.01.5--2.7Profession of the healthcare worker offering the vaccination^£^ Gynaecologist-Obstetrician110.05 General practitioner1.31.61.0--2.8 Hospital staff midwife0.60.90.6--1.3 Midwife (in private practice)1.12.20.9--5.1 Several different professionals0.91.20.7--1.9 Occupational doctor, national health insurance1.11.71.0--2.9Sources of information about influenza vaccination (multiple responses possible) No healthcare worker^c^11\< 0.001 At least one healthcare worker3.31.81.3--2.6^a^Adjusted odds ratio: determined by multivariate logistic regression of influenza vaccination for the variables with a *p*-value \< 0.20. The variables not significantly associated with vaccination (*p* \> 0.05) are not presented: the presence of at least one comorbidity^b^, perceived frequency of influenza, and perceived frequency of vaccine complications in mothers^b^95% confidence interval^c^All answers possible except healthcare workers: the media, discussion groups, family and friends, health authorities, and others¥p value was calculated by multivariate logistic regression analyses£ Only women who had received a vaccination recommendation were analysed (*n* = 1300)

Discussion {#Sec7}
==========

Our study examined the potential determinants of the influenza vaccination uptake amongst pregnant women in a single centre in France.

Overall, our findings highlight the importance of the healthcare worker in vaccination uptake. Indeed, vaccination recommendation by a healthcare provider strongly influence vaccination uptake (aOR 19). In addition to making a recommendation, the influence of healthcare worker was also vital in educating women about the influenza and the vaccine and providing reimbursement form.

Indeed, among factors that may be modified to improve the vaccination rate, we found, similar to other authors, that several are related to knowledge and perception of influenza, its vaccine and its potential complications \[[@CR13]--[@CR15], [@CR17], [@CR23], [@CR24]\]. Moreover, our study found that protecting the baby against influenza was the leading motivation for vaccination among those pregnant women who were vaccinated (83%). In a systematic review of the literature on the subject, 41% of the articles studied found that vaccine safety was a major concern among pregnant women, for all vaccines combined \[[@CR25]\]. Furthermore, our study demonstrates the role of healthcare professionals as an essential source of information for the pregnant women who are vaccinated. Inversely, sources of information such as television, radio, the print media, the internet, family and friends are associated with lower vaccination rates in our study and in the literature \[[@CR13], [@CR25], [@CR26]\]. Conversely, good knowledge of influenza and its vaccine was closely associated with vaccination among the women questioned in our study. This should provide incentives to implement measures to improve the quality of information provided to women by healthcare worker \[[@CR15], [@CR27]\].

Concerning the major impact of the recommendation and provision of the reimbursement form by healthcare worker, our results are corroborated by the data from the literature: an analysis by the CDC for the 2016--2017 influenza season in the US showed that the vaccination rate among pregnant women reached 70.5% among women whose providers recommended and offered the vaccination, 43.7% when the vaccine was recommended but not offered, and 14.8% when it was neither recommended nor offered \[[@CR20]\] (53%, 35 and 2% in our study).

In France, women must obtain a prescription from their GP or antenatal care provider, purchase the vaccine, and subsequently attend again to receive the vaccine. This process may be a significant barrier to the vaccine uptake. Several experiments are in process in France to study if getting the vaccine without prescription and injecting it at the same time in the drugstore can improve the vaccination coverage.

We found several other factors associated with increased vaccination rate but not easily modifiable by a public health program such as nulliparity \[[@CR15], [@CR17]\], history of preterm delivery or hospital based prenatal care in their first trimester of pregnancy \[[@CR15], [@CR28]\].

So, our study highlights the importance of incorporating education about the risk of flu and the safety/efficacy of vaccination into routine antenatal care. The pregnant women need to know that the vaccine protects them and their newborns from influenza infection and that there are very few vaccine complications for them and their babies. Our study suggests that this simple message delivered by a healthcare worker can improve the vaccination uptake.

Implications for future practice and research {#Sec8}
---------------------------------------------

Our study suggests that in order to increase influenza vaccine compliance among pregnant women, two principal actions should guide prenatal care policies: information about influenza and its vaccine by healthcare workers and cost-free access to the vaccine. As the role of professionals appears central, it would be useful to conduct a study in order to assess their knowledge and opinions about this vaccination and to help them to improve their practice by incorporating education about influenza vaccination during their routine antenatal care.

Strengths and limitations {#Sec9}
-------------------------

On the one hand, the prospective nature of our study, the number of women included, the high participation rate (87%), and the use of a self-completed questionnaire enabled us to limit the potential for bias as much as possible. On the other hand, its single-centre nature could have induced recruitment bias, and the responses cannot be taken as representative of all pregnant women. Another limitation might be that our participants were all recruited from a university hospital, and that our sample may therefore be missing subsets of the population that tend to be more anti-vaccination or receive less education, so future studies might benefit from recruiting over a wider geographical area and from different types of sites. Finally, vaccination status was reported by the women and there is therefore potentially susceptible to reporting bias, which has been partially corrected by checking the women's medical records.

Conclusions {#Sec10}
===========

Although the World Health Organization has recommended influenza vaccination for all pregnant women since 2012, only one third of the mothers in our study were vaccinated. Our study highlights that in order to increase influenza vaccination compliance among pregnant women, two principal actions should guide prenatal care policies: information about influenza and its vaccine be routinely given by healthcare workers and cost-free access to the vaccine.
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